Company Valuation: THUP MEDIPAR

Data adjusted to current consolidation scope
Fiscal Period: December 2022 2023 2024
Market Cap 1 50.47 45.59 32.21
Change - -9.66% -29.36%
Enterprise Value (EV) 1 49.31 45.33 27.53
Change - -8.07% -39.28%
P/E -35.5x -12.8x -6.86x
PBR 47.2x 132x 6.76x
PEG -1.3x -0x -1.07x
Capitalization / Revenue 20,846,420,900x 22,262,416,992x 43,463,801,619x
EV / Revenue - - -
EV / EBITDA - - -
EV / EBIT -40.7x -18x -6.98x
EV / FCF - - -
FCF Yield - - -
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 -0.2 -0.47 -0.5
Distribution rate - - -
Net sales 0.002421 0.002048 0.000741
EBITDA -1.208 -2.516 -3.942
EBIT 1 -1.211 -2.519 -3.946
Net income 1 -1.222 -3.324 -4
Net Debt 1 -1.155 -0.2592 -4.681
Reference price 2 7.100 6.000 3.430
Nbr of stocks (in thousands) 7,108 7,599 9,390
Announcement Date 3/31/23 3/20/24 3/11/25
1USD in Million2USD
Estimates


Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. TZUP Stock
  4. Valuation THUP MEDIPAR